These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 22044668)

  • 1. Inverse correlation of free and immune complex-sequestered anti-ADAMTS13 antibodies in a patient with acquired thrombotic thrombocytopenic purpura.
    Ferrari S; Knöbl P; Kolovratova V; Plaimauer B; Turecek PL; Varadi K; Rottensteiner H; Scheiflinger F
    J Thromb Haemost; 2012 Jan; 10(1):156-8. PubMed ID: 22044668
    [No Abstract]   [Full Text] [Related]  

  • 2. Persistence of circulating ADAMTS13-specific immune complexes in patients with acquired thrombotic thrombocytopenic purpura.
    Ferrari S; Palavra K; Gruber B; Kremer Hovinga JA; Knöbl P; Caron C; Cromwell C; Aledort L; Plaimauer B; Turecek PL; Rottensteiner H; Scheiflinger F
    Haematologica; 2014 Apr; 99(4):779-87. PubMed ID: 24241492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influenza A infection triggers thrombotic thrombocytopenic purpura by producing the anti-ADAMTS13 IgG inhibitor.
    Kosugi N; Tsurutani Y; Isonishi A; Hori Y; Matsumoto M; Fujimura Y
    Intern Med; 2010; 49(7):689-93. PubMed ID: 20371960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ADAMTS13 and anti-ADAMTS13 autoantibodies in thrombotic thrombocytopenic purpura - current perspectives and new treatment strategies.
    Tersteeg C; Verhenne S; Roose E; Schelpe AS; Deckmyn H; De Meyer SF; Vanhoorelbeke K
    Expert Rev Hematol; 2016; 9(2):209-21. PubMed ID: 26581428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ADAMTS13 and anti-ADAMTS13 antibodies as markers for recurrence of acquired thrombotic thrombocytopenic purpura during remission.
    Peyvandi F; Lavoretano S; Palla R; Feys HB; Vanhoorelbeke K; Battaglioli T; Valsecchi C; Canciani MT; Fabris F; Zver S; Réti M; Mikovic D; Karimi M; Giuffrida G; Laurenti L; Mannucci PM
    Haematologica; 2008 Feb; 93(2):232-9. PubMed ID: 18223285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. VH1-69 germline encoded antibodies directed towards ADAMTS13 in patients with acquired thrombotic thrombocytopenic purpura.
    Pos W; Luken BM; Kremer Hovinga JA; Turenhout EA; Scheiflinger F; Dong JF; Fijnheer R; Voorberg J
    J Thromb Haemost; 2009 Mar; 7(3):421-8. PubMed ID: 19054323
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-ADAMTS13 IgG autoantibodies present in healthy individuals share linear epitopes with those in patients with thrombotic thrombocytopenic purpura.
    Grillberger R; Casina VC; Turecek PL; Zheng XL; Rottensteiner H; Scheiflinger F
    Haematologica; 2014 Apr; 99(4):e58-60. PubMed ID: 24532042
    [No Abstract]   [Full Text] [Related]  

  • 8. Pathogenicity of Anti-ADAMTS13 Autoantibodies in Acquired Thrombotic Thrombocytopenic Purpura.
    Thomas MR; de Groot R; Scully MA; Crawley JT
    EBioMedicine; 2015 Aug; 2(8):942-52. PubMed ID: 26425702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple domains of ADAMTS13 are targeted by autoantibodies against ADAMTS13 in patients with acquired idiopathic thrombotic thrombocytopenic purpura.
    Zheng XL; Wu HM; Shang D; Falls E; Skipwith CG; Cataland SR; Bennett CL; Kwaan HC
    Haematologica; 2010 Sep; 95(9):1555-62. PubMed ID: 20378566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogenesis and treatment of acquired idiopathic thrombotic thrombocytopenic purpura.
    Peyvandi F; Palla R; Lotta LA
    Haematologica; 2010 Sep; 95(9):1444-7. PubMed ID: 20807984
    [No Abstract]   [Full Text] [Related]  

  • 11. IgG subclass distribution of anti-ADAMTS13 antibodies in patients with acquired thrombotic thrombocytopenic purpura.
    Ferrari S; Mudde GC; Rieger M; Veyradier A; Kremer Hovinga JA; Scheiflinger F
    J Thromb Haemost; 2009 Oct; 7(10):1703-10. PubMed ID: 19682238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acquired thrombotic thrombocytopenic purpura: ADAMTS13 activity, anti-ADAMTS13 autoantibodies and risk of recurrent disease.
    Lämmle B; Kremer Hovinga JA; George JN
    Haematologica; 2008 Feb; 93(2):172-7. PubMed ID: 18245649
    [No Abstract]   [Full Text] [Related]  

  • 13. Acquired TTP: ADAMTS13 meets the immune system.
    Verbij FC; Fijnheer R; Voorberg J; Sorvillo N
    Blood Rev; 2014 Nov; 28(6):227-34. PubMed ID: 25213289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Congenital ADAMTS13 deficiency: a rare mimicker of immune thrombocytopenic purpura.
    Quintero V; Garcia-Pose A; Barrios-Tascon A; Pacheco-Cumani M
    J Pediatr Hematol Oncol; 2014 Nov; 36(8):653-5. PubMed ID: 24942015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [anti-ADAMTS13 autoantibodies in patients with thrombotic thrombocytopenic purpura].
    Matsumoto M
    Nihon Rinsho Meneki Gakkai Kaishi; 2013; 36(2):95-103. PubMed ID: 23629429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advantages and limits of ADAMTS13 testing in thrombotic thrombocytopenic purpura.
    Franchini M; Mannucci PM
    Blood Transfus; 2008 Jul; 6(3):127-35. PubMed ID: 18705236
    [No Abstract]   [Full Text] [Related]  

  • 17. Humoral immune response to ADAMTS13 in acquired thrombotic thrombocytopenic purpura.
    Pos W; Luken BM; Sorvillo N; Kremer Hovinga JA; Voorberg J
    J Thromb Haemost; 2011 Jul; 9(7):1285-91. PubMed ID: 21535387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple B-cell clones producing antibodies directed to the spacer and disintegrin/thrombospondin type-1 repeat 1 (TSP1) of ADAMTS13 in a patient with acquired thrombotic thrombocytopenic purpura.
    Luken BM; Kaijen PH; Turenhout EA; Kremer Hovinga JA; van Mourik JA; Fijnheer R; Voorberg J
    J Thromb Haemost; 2006 Nov; 4(11):2355-64. PubMed ID: 16898953
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bortezomib induces clinical remission and reduction of ADAMTS13 inhibitory antibodies in relapsed refractory idiopathic thrombotic thrombocytopenic purpura.
    Mazepa MA; Raval JS; Moll S; Ma A; Park YA
    Br J Haematol; 2014 Mar; 164(6):900-2. PubMed ID: 24345005
    [No Abstract]   [Full Text] [Related]  

  • 20. The splenic autoimmune response to ADAMTS13 in thrombotic thrombocytopenic purpura contains recurrent antigen-binding CDR3 motifs.
    Schaller M; Vogel M; Kentouche K; Lämmle B; Kremer Hovinga JA
    Blood; 2014 Nov; 124(23):3469-79. PubMed ID: 25261198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.